<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04336930</url>
  </required_header>
  <id_info>
    <org_study_id>2019PI275</org_study_id>
    <nct_id>NCT04336930</nct_id>
  </id_info>
  <brief_title>Evaluation of the &quot;Pupillary Pain Index&quot; in Neurological Prognosis After Cardiac Arrest</brief_title>
  <acronym>CAPPI</acronym>
  <official_title>Evaluation of the Pupillary Dilatation Reflex With the &quot;Pupillary Pain Index&quot; in Neurological Prognosis After Cardiac Arrest</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Central Hospital, Nancy, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Central Hospital, Nancy, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Two-thirds of patients admitted to the Intensive Care Unit after a cardiac arrest die in the&#xD;
      context of treatment withdrawal after a multimodal evaluation that determines an unfavorable&#xD;
      neurological outcome.&#xD;
&#xD;
      This study will evaluate the Pupillary Pain Index (PPI) in the neurological prognosis after&#xD;
      cardiac arrest. The PPI is determined by recording of pupillary dilatation with a&#xD;
      videopupillometer after a calibrated and incremented nociceptive stimulus on a cutaneous&#xD;
      metamere.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cardiorespiratory arrest is associated with high mortality and morbidity rates. The direct&#xD;
      consequence of a cardio-circulatory arrest is the absence of blood flow allowing oxygenation&#xD;
      of the organs and consequently formation of ischemic lesions. Anoxic cerebral lesions are&#xD;
      common in the aftermath of a cardiac arrest and often lead to the death of patients when&#xD;
      active therapies are stopped after a multimodal prognostication that indicates that a poor&#xD;
      outcome is very likely.&#xD;
&#xD;
      It is of paramount importance to optimize the sensitivity of the prognostication strategy in&#xD;
      detecting good neurological outcome. A multimodal approach to the prognostic assessment is&#xD;
      essential, and must include at least clinical examination, electrophysiology exploration&#xD;
      (electroencephalography and/or evoked potentials) and biomarker analysis.&#xD;
&#xD;
      Although the most reliable predictors did not give false positives in most studies, none of&#xD;
      them, considered individually, can establish an unfavorable prognosis with an absolute degree&#xD;
      of certitude. For these reasons it is interesting to evaluate new prognostication tools.&#xD;
&#xD;
      The videopupillometry allows precise, reproducible and repeated measurement of changes in&#xD;
      pupil diameter in response to a painful or a luminous stimulus. Pupillary pain reflex&#xD;
      analysis is usually used to assess the degree of analgesia in a non-communicative patient&#xD;
      during general anesthesia and neuromuscular blockade. The PPI score is determined at the&#xD;
      bedside by recording pupillary dilatation after a calibrated and incremented nociceptive&#xD;
      stimulus (electrical current between 5 and 60mA) applied to a skin metamere with two&#xD;
      electrodes.&#xD;
&#xD;
      Automated pupillometry measurement has been recently developed to help support&#xD;
      prognostication, with a quantitative pupillary light reflex measurement. The aim of this&#xD;
      study is to evaluate the Pupillary Pain Index in the neurological prognosis after a cardiac&#xD;
      arrest by correlating the PPI at 48h from the patient's arrival to the CPC score at 3 months.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 1, 2021</start_date>
  <completion_date type="Anticipated">July 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Score Cerebral Performance Category (CPC)</measure>
    <time_frame>3 months</time_frame>
    <description>Good outcome defined as CPC 1-2, poor outcome defined as CPC 3-5</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Characteristics of electroencephalography pattern</measure>
    <time_frame>Day 2, day 3, day 5, day 7</time_frame>
    <description>Classification of Synek, type of pattern (Very malignant, malignant or benign)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biomarkers</measure>
    <time_frame>24 hours, 48 hours</time_frame>
    <description>Value of seric Neuron Specific Enolase</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glasgow motor score</measure>
    <time_frame>24 hours, 48 hours, day 5, day 7</time_frame>
    <description>Motor response component of the Glasgow Coma Scale, ranging from 1 (no response) to 6 (normal response)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU parameters</measure>
    <time_frame>Day 14</time_frame>
    <description>Ventilator days, Length of stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evoked Potentials</measure>
    <time_frame>Day 14</time_frame>
    <description>Presence or absence of the N20 component of the evoked potentials</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neurological pupil index</measure>
    <time_frame>Day 2, day 3</time_frame>
    <description>standardized evaluation of pupil reactivity ranging from 0 (sluggish or abnormal pupils) to 5 (normally reactive pupils)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diameter of the pupil</measure>
    <time_frame>24 hours, 48 hours, 72 hours</time_frame>
    <description>In millimeters (pupillometry measure)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of pupil dilatation</measure>
    <time_frame>24 hours, 48 hours, 72 hours</time_frame>
    <description>Pupillometry measure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Latency of pupil dilatation</measure>
    <time_frame>24 hours, 48 hours, 72 hours</time_frame>
    <description>In milliseconds (pupillometry measure)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Velocity of pupil dilatation</measure>
    <time_frame>24 hours, 48 hours, 72 hours</time_frame>
    <description>In millimeters per second (pupillometry measure)</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Cardiac Arrest</condition>
  <condition>Post-Anoxic Coma</condition>
  <condition>Anoxic Brain Injury</condition>
  <arm_group>
    <arm_group_label>Cardiac Arrest group</arm_group_label>
    <description>Patients remaining comatose after a cardiac arrest</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Pupillary pain index (PPI)</intervention_name>
    <description>Measurement of PPI with a pupillometer</description>
    <arm_group_label>Cardiac Arrest group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients remaining comatose after cardiac arrest&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Admission to the ICU after cardiac arrest&#xD;
&#xD;
          -  Age &gt; 18 years&#xD;
&#xD;
          -  Presenting a Glasgow score of &lt;8 at admission&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Ocular pathology making pupillometry impossible.&#xD;
&#xD;
          -  Patient under guardianship or curatorship&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Matthieu Koszutski, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nancy Teaching Hospital, CHU de Nancy</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Matthieu KOSZUTSKI, Dr</last_name>
    <phone>+33383153017</phone>
    <email>m.koszutski@chru-nancy.fr</email>
  </overall_contact>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>March 10, 2020</study_first_submitted>
  <study_first_submitted_qc>April 5, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 7, 2020</study_first_posted>
  <last_update_submitted>May 21, 2021</last_update_submitted>
  <last_update_submitted_qc>May 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pupillometry</keyword>
  <keyword>Pupillary Pain Index</keyword>
  <keyword>Brain ischemia</keyword>
  <keyword>Heart arrest</keyword>
  <keyword>Neuroprognostication</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Injuries</mesh_term>
    <mesh_term>Heart Arrest</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

